Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEZ763 in Healthy Subjects and Patients with Type 2 Diabetes
NCT01619332Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of LEZ763 in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Mar 2012; status: completed.
02
Drugs
LEZ763
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01619332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01619332.